Home > Insider Trading > Theseus Pharmaceuticals Inc.

Theseus Pharmaceuticals Inc. (THRX)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
51 - 60
Next >>

Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up

Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into animal health products...

Keep Reading →

April 26th, 2013 - News

Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech

With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

April 20th, 2013 - News

Price-Gainers News: Theravance Inc (THRX), Travelzoo Inc (TZOO), Arch Coal Inc (ACI)

Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), GlaxoSmithKline plc (NYSE:GSK), Travelzoo Inc. (NASDAQ:TZOO), Arch Coal Inc (NYSE:ACI), Overstock.com, Inc.

Keep Reading →

April 18th, 2013 - News

Theravance Inc (THRX): Why Shares Rose Higher

What: Shares of Theravance Inc (NASDAQ:THRX), a biopharmaceutical company that focuses on central nervous system and respiratory disorders, leapt as much as 19% -- its second double-digit jump this week...

Keep Reading →

April 18th, 2013 - News

Biopharma News: Theravance Inc (THRX), VIVUS, Inc. (VVUS), Amgen, Inc. (AMGN)

Theravance Inc (NASDAQ:THRX) rose the most in a year after a staff report by U.S.

Keep Reading →

April 15th, 2013 - News

Theravance Inc (THRX): Here's One Thing To Know About The Stock Today

Theravance Inc (NASDAQ:THRX) has experienced a decrease in support from the world's most elite money managers of late, but insiders on the whole appear bullish.

Keep Reading →

April 15th, 2013 - News

Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK), and Three 'Cannot Miss' FDA Actions This Week

Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration actions expected in the ...

Keep Reading →

April 14th, 2013 - News

Hedge Funds Aren't Crazy About Theravance Inc (THRX) Anymore - Arena Pharmaceuticals, Inc. (ARNA), Questcor Pharmaceuticals Inc (QCOR)

If you'd ask most market participants, hedge funds are viewed as worthless, old financial tools of years past.

Keep Reading →

April 6th, 2013 - News

This Week in Biotech: Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK)

With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

March 10th, 2013 - News

How Sequestration Will Affect the Health-Care Sector and Your Pocketbook: Gilead Sciences, Inc. (GILD), Life Technologies Corp. (LIFE)

Stop me if you've heard this joke before: "Two political parties walk into a bar; both point the finger at each other for the country's fiscal mess, yet neither is willing to budge an inch from their ...

Keep Reading →

March 6th, 2013 - News